Self-replicating Replicon-RNA Delivery to Dendritic Cells by Chitosan-nanoparticles for Translation In Vitro and In Vivo

Platta, 2011, Endocytosis and signaling, Curr Opin Cell Biol., 23, 393, 10.1016/j.ceb.2011.03.008 Kumari, 2010, Endocytosis unplugged: multiple ways to enter the cell, Cell Res., 20, 256, 10.1038/cr.2010.19 Sorkin, 2009, Endocytosis and signalling: intertwining molecular networks, Nat Rev Mol Cell Biol., 10, 609, 10.1038/nrm2748 McCullough, 2012, Functional RNA delivery targeted to dendritic cells by synthetic nanoparticles, Ther Deliv, 3, 1077, 10.4155/tde.12.90 Randolph, 2008, Antigen presentation by monocytes and monocyte-derived cells, Curr Opin Immunol, 20, 52, 10.1016/j.coi.2007.10.010 Théry, 2001, The cell biology of antigen presentation in dendritic cells, Curr Opin Immunol, 13, 45, 10.1016/S0952-7915(00)00180-1 Jensen, 2007, Recent advances in antigen processing and presentation, Nat Immunol, 8, 1041, 10.1038/ni1516 Vyas, 2008, The known unknowns of antigen processing and presentation, Nat Rev Immunol, 8, 607, 10.1038/nri2368 Markov, 2012, Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets, J Control Release, 160, 200, 10.1016/j.jconrel.2011.11.034 Midoux, 2009, Chemical vectors for gene delivery: a current review on polymers, peptides and lipids containing histidine or imidazole as nucleic acids carriers, Br J Pharmacol, 157, 166, 10.1111/j.1476-5381.2009.00288.x Perche, 2011, Enhancement of dendritic cells transfection in vivo and of vaccination against B16F10 melanoma with mannosylated histidylated lipopolyplexes loaded with tumor antigen messenger RNA., Nanomedicine, 7, 445, 10.1016/j.nano.2010.12.010 Perche, 2011, Selective gene delivery in dendritic cells with mannosylated and histidylated lipopolyplexes, J Drug Target, 19, 315, 10.3109/1061186X.2010.504262 Pichon, 2013, Mannosylated and histidylated LPR technology for vaccination with tumor antigen mRNA, Methods Mol Biol., 969, 247, 10.1007/978-1-62703-260-5_16 Tratschin, 2008, Pestivirus replicons providing an RNA-based viral vector system Atkins, 2008, Therapeutic and prophylactic applications of alphavirus vectors, Expert Rev Mol Med, 10, e33, 10.1017/S1462399408000859 Khromykh, 2000, Replicon-based vectors of positive strand RNA viruses, Curr Opin Mol Ther, 2, 555 Lundstrom, 2002, Alphavirus-based vaccines, Curr Opin Mol Ther, 4, 28 Rayner, 2002, Alphavirus vectors and vaccination, Rev Med Virol, 12, 279, 10.1002/rmv.360 Pushko, 1997, Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo, Virology, 239, 389, 10.1006/viro.1997.8878 Pijlman, 2006, Kunjin virus replicons: an RNA-based, non-cytopathic viral vector system for protein production, vaccine and gene therapy applications, Expert Opin Biol Ther, 6, 135, 10.1517/14712598.6.2.135 Johansson, 2012, Intradermal electroporation of naked replicon RNA elicits strong immune responses, PLoS One, 7, e29732, 10.1371/journal.pone.0029732 Suter, 2011, Immunogenic and replicative properties of classical swine fever virus replicon particles modified to induce IFN-α/β and carry foreign genes, Vaccine, 29, 1491, 10.1016/j.vaccine.2010.12.026 Palucka, 2010, Designing vaccines based on biology of human dendritic cell subsets, Immunity, 33, 464, 10.1016/j.immuni.2010.10.007 Frey, 2006, Classical swine fever virus replicon particles lacking the Erns gene: a potential marker vaccine for intradermal application, Vet Res., 37, 655, 10.1051/vetres:2006028 Schütz, 2009, Fate of hydrophilic nanoparticles in biological environments, Chimia, 63, 220, 10.2533/chimia.2009.220 Summerfield, 2003, Porcine peripheral blood dendritic cells and natural interferon-producing cells, Immunology, 110, 440, 10.1111/j.1365-2567.2003.01755.x Summerfield, 2009, The porcine dendritic cell family, Dev Comp Immunol, 33, 299, 10.1016/j.dci.2008.05.005 Gilleron, 2013, Image-based analysis of lipid nanoparticle-mediated siRNA delivery, intracellular trafficking and endosomal escape, Nat Biotechnol, 31, 638, 10.1038/nbt.2612 Rehman, 2013, Mechanism of polyplex- and lipoplex-mediated delivery of nucleic acids: real-time visualization of transient membrane destabilization without endosomal lysis, ACS Nano, 7, 3767, 10.1021/nn3049494 Collnot, 2012, Nano- and microparticulate drug carriers for targeting of the inflamed intestinal mucosa, J Control Release, 161, 235, 10.1016/j.jconrel.2012.01.028 Danhier, 2012, PLGA-based nanoparticles: an overview of biomedical applications, J Control Release, 161, 505, 10.1016/j.jconrel.2012.01.043 Lai, 2008, Delivery strategies of melanoma vaccines: an overview, Expert Opin Drug Deliv, 5, 979, 10.1517/17425247.5.9.979 Ceppi, 2005, Double-stranded secondary structures on mRNA induce type I interferon (IFN alpha/beta) production and maturation of mRNA-transfected monocyte-derived dendritic cells, J Gene Med, 7, 452, 10.1002/jgm.685 Hoerr, 2000, In vivo application of RNA leads to induction of specific cytotoxic T lymphocytes and antibodies, Eur J Immunol, 30, 1, 10.1002/1521-4141(200001)30:1<1::AID-IMMU1>3.0.CO;2-# Mockey, 2007, mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes, Cancer Gene Ther, 14, 802, 10.1038/sj.cgt.7701072 Fang, 2001, Interactions of phospholipid bilayer with chitosan: effect of molecular weight and pH, Biomacromolecules, 2, 1161, 10.1021/bm015548s Hafez, 2001, On the mechanism whereby cationic lipids promote intracellular delivery of polynucleic acids, Gene Ther, 8, 1188, 10.1038/sj.gt.3301506 Varkouhi, 2011, Endosomal escape pathways for delivery of biologicals, J Control Release, 151, 220, 10.1016/j.jconrel.2010.11.004 He, 2010, Effects of particle size and surface charge on cellular uptake and biodistribution of polymeric nanoparticles, Biomaterials, 31, 3657, 10.1016/j.biomaterials.2010.01.065 Thiele, 2001, Evaluation of particle uptake in human blood monocyte-derived cells in vitro. Does phagocytosis activity of dendritic cells measure up with macrophages?, J Control Release, 76, 59, 10.1016/S0168-3659(01)00412-6 Manolova, 2008, Nanoparticles target distinct dendritic cell populations according to their size, Eur J Immunol, 38, 1404, 10.1002/eji.200737984 Sharma, 2012, Synthetic virus-like particles target dendritic cell lipid rafts for rapid endocytosis primarily but not exclusively by macropinocytosis, PLoS One, 7, e43248, 10.1371/journal.pone.0043248 Vázquez-Calvo, 2012, Acid-dependent viral entry, Virus Res., 167, 125, 10.1016/j.virusres.2012.05.024 Ruggli, 1996, Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA, J Virol, 70, 3478, 10.1128/JVI.70.6.3478-3487.1996 Schütz, 2011, Cell response to the exposure to chitosan-TPP//alginate nanogels, Biomacromolecules, 12, 4153, 10.1021/bm201231x McCullough, 1999, Intermediate stages in monocyte-macrophage differentiation modulate phenotype and susceptibility to virus infection, Immunology, 98, 203, 10.1046/j.1365-2567.1999.00867.x Guzylack-Piriou, 2004, Type-A CpG oligonucleotides activate exclusively porcine natural interferon-producing cells to secrete interferon-alpha, tumour necrosis factor-alpha and interleukin-12, Immunology, 112, 28, 10.1111/j.1365-2567.2004.01856.x Summerfield, 2003, C-kit positive porcine bone marrow progenitor cells identified and enriched using recombinant stem cell factor, J Immunol Methods, 280, 113, 10.1016/S0022-1759(03)00273-4 Python, 2013, Efficient sensing of infected cells in absence of virus particles by plasmacytoid dendritic cells is blocked by the viral ribonuclease E(rns.), PLoS Pathog, 9, e1003412, 10.1371/journal.ppat.1003412 Borsutzky, 2006, Efficient systemic and mucosal responses against the HIV-1 Tat protein by prime/boost vaccination using the lipopeptide MALP-2 as adjuvant, Vaccine, 24, 2049, 10.1016/j.vaccine.2005.11.025